Turn Therapeutics Inc. financial data

Symbol
TTRX on Nasdaq
Location
Westlake Village, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29,445,183 shares
Common Stock, Shares, Outstanding 28,022,826 shares
Common Stock, Value, Issued $2,802 USD
Weighted Average Number of Shares Outstanding, Basic 27,975,207 shares 5%
Weighted Average Number of Shares Outstanding, Diluted 27,975,207 shares 5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $158,699 USD 3.5%
General and Administrative Expense $1,754,856 USD 238%
Operating Income (Loss) $1,913,555 USD -184%
Nonoperating Income (Expense) $9,371 USD 43%
Net Income (Loss) Attributable to Parent $1,904,184 USD -186%
Earnings Per Share, Basic -0.07 USD/shares -133%
Earnings Per Share, Diluted -0.07 USD/shares -133%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $513,695 USD 3.1%
Assets, Current $3,294,740 USD
Operating Lease, Right-of-Use Asset $89,423 USD
Intangible Assets, Net (Excluding Goodwill) $904,885 USD
Assets $4,297,630 USD
Liabilities, Current $2,309,254 USD
Contract with Customer, Liability, Noncurrent $1,438,013 USD
Operating Lease, Liability, Noncurrent $46,344 USD
Liabilities $3,793,611 USD
Retained Earnings (Accumulated Deficit) $22,669,163 USD
Stockholders' Equity Attributable to Parent $504,019 USD
Liabilities and Equity $4,297,630 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500,000,000 shares
Common Stock, Shares, Issued 28,022,826 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3,106,156 USD 294%
Operating Lease, Liability, Current $44,829 USD
Preferred Stock, Shares Authorized 100,000,000 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares